A recent New England Journal of Medicine article proposed "endothelialitis" as the unifying mechanism for the widespread pathology of COVID-19. In a prior Medscape interview, Medscape contributor ...

Please provide your email address to receive an email when new articles are posted on . Researchers from the Netherlands have identified benefits and risks associated with stopping renin-angiotensin ...

The renin–angiotensin system (RAS) is a highly regulated hormonal cascade that plays a central role in the control of blood pressure and the maintenance of renal homeostasis. Its components, including ...

Ditching renin-angiotensin system (RAS) inhibitors in advanced chronic kidney disease (CKD) didn't help to slow kidney decline, according to the STOP ACEi trial. These findings were presented at the ...

pills Findings may aid physicians in their clinical decision-making in the absence of randomized clinical trial data, according to investigators. Halting renin-angiotensin system (RAS) inhibitors in ...

The renin-angiotensin system (RAS) becomes active at low blood pressure and forms angiotensin II, a hormone that causes blood vessels to constrict, causing blood pressure to rise again. The enzyme ...

If renin-angiotensin system inhibitors are indicated in patients with advanced CKD, they should not be stopped just because of low eGFR, investigators concluded. Discontinuing renin-angiotensin system ...

ACE inhibitors have emerged as the treatment of choice for patients with all degrees of heart failure. The first ACE inhibitor trial to show a reduction in mortality in patients with heart failure was ...

Circulating tumor cells (CTC) in mesothelioma and its cytomorphological and immunohistochemical correlation with the primary tumor specimens. Fluorodeoxiglucose (FDG)-avidity at positron emission ...

Please provide your email address to receive an email when new articles are posted on . Discontinuation of RAS therapy before major noncardiac surgery did not impact postoperative outcomes vs.